Societal Cdmo San Diego, Llc
Dba Irisys Inc
CAGE Code: 7B0Z1
NCAGE Code: 7B0Z1
Status: Active
Type: Commercial Supplier
Summary
Societal Cdmo San Diego, Llc, Dba Irisys Inc is an Active Commercial Supplier with the Cage Code 7B0Z1.
Address
6828 Nancy Ridge Dr
Ste 100
San Diego CA 92121-2224
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Technet Jarecki Engineering Circle Intl Temple Ralph Corona Consulting Btg Technology Systems Quality Technology Services, Inc. P&D Consultants Inc. Nova Commercial Co Inc Precision Metal Products Co Frut Stix Co Div Of Lafayette Foods Lynx Systems Kjos Neil A Music Co Circle M Construction Lopez Dunn Ramirez And Associates Morton Equipment And Supply Company G G B Drywall Co Ocean Sensors Inc King Communications Compucom Systems Inc
Frequently Asked Questions (FAQ) for CAGE 7B0Z1
- What is CAGE Code 7B0Z1?
- 7B0Z1 is the unique identifier used by NATO Organizations to reference the physical entity known as Societal Cdmo San Diego, Llc Dba Irisys Inc located at 6828 Nancy Ridge Dr, Ste 100, San Diego CA 92121-2224, United States.
- Who is CAGE Code 7B0Z1?
- 7B0Z1 refers to Societal Cdmo San Diego, Llc Dba Irisys Inc located at 6828 Nancy Ridge Dr, Ste 100, San Diego CA 92121-2224, United States.
- Where is CAGE Code 7B0Z1 Located?
- CAGE Code 7B0Z1 is located in San Diego, CA, USA.
- How Many NSNs Does CAGE Code 7B0Z1 Supply?
- CAGE Code 7B0Z1 has been assigned as an approved source for 3 NSNs (National Stock Numbers and NATO Stock Numbers).
Contracting History for CAGE 7B0Z1 Most Recent 25 Records
- 75N91023F00001
- Metarrestin Storage And Stability Testing Services
- 12 Sep 2023
- Metarrestin Storage And Stability Testing Services
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $78,600.00
- Department Of Health And Human Services (Hhs)
- 75N95023F00001
- Societal Is A Small Business Concern For Dosage Form Development, Manufacture, And Stability Studies Of Ncgc72
- 28 Sep 2023
- Societal Is A Small Business Concern For Dosage Form Development, Manufacture, And Stability Studies Of Ncgc72
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $182,902.00
- Department Of Health And Human Services (Hhs)
- 36C24E23N0099
- Placebo & Active Imiquimod
- 30 Jun 2023
- Placebo & Active Imiquimod
- Rpo East (36C24e)
- Department Of Veterans Affairs (Va)
- $1,136,781.80
- Department Of Veterans Affairs (Va)
- 36C24E23N0099
- Placebo & Active Imiquimod
- 28 Apr 2023
- Placebo & Active Imiquimod
- Rpo East (36C24e)
- Department Of Veterans Affairs (Va)
- $1,261,779.80
- Department Of Veterans Affairs (Va)
- 36C24E23D0025
- Pharmacuetical Manufacturing - Actice & Placebo - Imiquimod
- 30 Jun 2023
- Pharmacuetical Manufacturing - Actice & Placebo - Imiquimod
- Rpo East (36C24e)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36C24E23D0025
- Pharmacuetical Manufacturing - Actice & Placebo - Imiquimod
- 28 Apr 2023
- Pharmacuetical Manufacturing - Actice & Placebo - Imiquimod
- Rpo East (36C24e)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 75N95022F00001
- This Task Order (To) Is To Provide Dosage Form Development, Manufacture And Stability Studies Of Orc-13661 For Phase Ii Clinical Trial
- 27 Sep 2022
- This Task Order (To) Is To Provide Dosage Form Development, Manufacture And Stability Studies Of Orc-13661 For Phase Ii Clinical Trial
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $555,749.00
- Department Of Health And Human Services (Hhs)
- 75N91022F00004
- Next Dtp-22-018, Gmp Production Of 40 Mg Z-Endoxifen (Nsc 774768) Capsules Contract/To#Dctd-2022-1007 Development & Manufacture Of Oral & Topical Dosage Forms - Prb
- 22 Jun 2022
- Next Dtp-22-018, Gmp Production Of 40 Mg Z-Endoxifen (Nsc 774768) Capsules Contract/To#Dctd-2022-1007 Development & Manufacture Of Oral & Topical Dosage Forms - Prb
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $189,535.00
- Department Of Health And Human Services (Hhs)
- 75N91022F00003
- Next Dtp-22-013, Production Of Tak-243 Injectable For Clinical Use And Study The Shelf-Life. Contract/To#Dctc-2022-1006, Development & Manufacture Of Oral & Topical Dosage Forms - Prb
- 22 Mar 2023
- Next Dtp-22-013, Production Of Tak-243 Injectable For Clinical Use And Study The Shelf-Life. Contract/To#Dctc-2022-1006, Development & Manufacture Of Oral & Topical Dosage Forms - Prb
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $692,051.00
- Department Of Health And Human Services (Hhs)
- 75N91022F00003
- Next Dtp-22-013, Production Of Tak-243 Injectable For Clinical Use And Study The Shelf-Life. Contract/To#Dctc-2022-1006, Development & Manufacture Of Oral & Topical Dosage Forms - Prb
- 7 Apr 2022
- Next Dtp-22-013, Production Of Tak-243 Injectable For Clinical Use And Study The Shelf-Life. Contract/To#Dctc-2022-1006, Development & Manufacture Of Oral & Topical Dosage Forms - Prb
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $509,151.00
- Department Of Health And Human Services (Hhs)
- 75N91022F00003
- Next Dtp-22-013, Production Of Tak-243 Injectable For Clinical Use And Study The Shelf-Life. Contract/To#Dctc-2022-1006, Development & Manufacture Of Oral & Topical Dosage Forms - Prb
- 17 Aug 2022
- Next Dtp-22-013, Production Of Tak-243 Injectable For Clinical Use And Study The Shelf-Life. Contract/To#Dctc-2022-1006, Development & Manufacture Of Oral & Topical Dosage Forms - Prb
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $639,151.00
- Department Of Health And Human Services (Hhs)
- 75N91022F00002
- Task Order Is To Have The Engineering Batch And The Production Batch Completed Under The Cgmp Provided To The Government Along With The Shelf-Life Study For The Initial Amounts. The Base Amounts Of Both Engineering Batch And The Cgmp Batch Conditions
- 29 Nov 2023
- Task Order Is To Have The Engineering Batch And The Production Batch Completed Under The Cgmp Provided To The Government Along With The Shelf-Life Study For The Initial Amounts. The Base Amounts Of Both Engineering Batch And The Cgmp Batch Conditions
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $378,130.00
- Department Of Health And Human Services (Hhs)
- 75N91022F00002
- Production Of An Engineering Batch, Cgmp Batch, Delivery, And Shelf-Life Study Of Ammonium Tetrathiomolibdate (Attm) Capsules For Use In Clinical Trial For Possible Cancer Treatment.
- 8 Mar 2022
- Production Of An Engineering Batch, Cgmp Batch, Delivery, And Shelf-Life Study Of Ammonium Tetrathiomolibdate (Attm) Capsules For Use In Clinical Trial For Possible Cancer Treatment.
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $413,130.00
- Department Of Health And Human Services (Hhs)
- 36C24E22D0006
- Imiquimod Research Study
- 23 Dec 2021
- Imiquimod Research Study
- Rpo East (36C24e)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36C24E22D0006
- Imiquimod Research Study
- 8 Jun 2022
- Imiquimod Research Study
- Rpo East (36C24e)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36C24E22N0017
- Imiquimod
- 16 Nov 2022
- Imiquimod
- Rpo East (36C24e)
- Department Of Veterans Affairs (Va)
- $51,000.00
- Department Of Veterans Affairs (Va)
- 36C24E22N0017
- Imiquimod
- 8 Jun 2022
- Imiquimod
- Rpo East (36C24e)
- Department Of Veterans Affairs (Va)
- $796,700.00
- Department Of Veterans Affairs (Va)
- 36C24E22N0017
- Imiquimod
- 23 Dec 2021
- Imiquimod
- Rpo East (36C24e)
- Department Of Veterans Affairs (Va)
- $796,700.00
- Department Of Veterans Affairs (Va)
- 75N95021F00003
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- 24 Sep 2021
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,879,582.00
- Department Of Health And Human Services (Hhs)
- 75N95021F00003
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- 31 Mar 2022
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,962,360.00
- Department Of Health And Human Services (Hhs)
- 75N95021F00003
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- 20 Jul 2023
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,986,960.00
- Department Of Health And Human Services (Hhs)
- 75N95021F00003
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- 23 Jun 2023
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,981,349.00
- Department Of Health And Human Services (Hhs)
- 75N95021F00003
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- 19 Aug 2022
- Dosage Form Development, Manufacture, And Stability Studies Of Nes-100 Nasal Spray
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $1,981,349.00
- Department Of Health And Human Services (Hhs)
- 75N91021F00107
- Exercise Optional Task 3 And Extend Pop Accordingly
- 24 Mar 2023
- Exercise Optional Task 3 And Extend Pop Accordingly
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $590,499.65
- Department Of Health And Human Services (Hhs)
- 75N91021F00107
- Development & Manufacture Of Oral & Topical Dosage Forms - Novobiocin Capsule Production Base (Task 1) 12 Months & Option 1 (Task 2) A Cgmp Batch Shelf-Life Study 36 Months Prb
- 16 Apr 2021
- Development & Manufacture Of Oral & Topical Dosage Forms - Novobiocin Capsule Production Base (Task 1) 12 Months & Option 1 (Task 2) A Cgmp Batch Shelf-Life Study 36 Months Prb
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $412,499.85
- Department Of Health And Human Services (Hhs)
Supply Items Approved for CAGE 7B0Z1 Page 1 of 1
- DONNATAL ELIXIR
- RNCC: 3 | RNVC: 1 | DAC: 4
- NDC59212-0425-10
- RNCC: 3 | RNVC: 2 | DAC: 4
- NDC00591-2884-01
- RNCC: 3 | RNVC: 1 | DAC: 4